A Prospective, randomized, controlled double masked trial to assess the performance of Myoslow lens in slowing myopia progression in children. The following study measures will be assessed: * Demographics and medical history * Current spectacles * Best Corrected Visual Acuity (BCVA) assessed by Measurement and Summation (M\&S) system * Biometry * Cover test * Stereopsis * Ocular Motility * Pupil responses * Cycloplegic refraction * Fundus Examination * Vision related quality of life using the questionnaire Pediatric Refractive Error Profile (PREP)2 * Adverse Events
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
125
The Myoslow spectacle lens is based on the Defocus Incorporated Multiple Segments (DIMS) mechanism of action. This lens provides the same optical image as the Defocusing Incorporated Soft Contact Lens (DISC) without the drawbacks inherent with contact lens fitting.
Single vision glasses
Sheba MC
Ramat Gan, Israel
spherical equivalent error
Change in spherical equivalent refractive error from baseline to 24-month visit
Time frame: 24 months
Axial length
Mean change in axial length (mm) from baseline at 24-month visit (Based on Biometry)
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.